{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:23:29Z","timestamp":1791321809933,"version":"4.3.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014269","name":"Uniwersytet Medyczny w Bia\u0142ymstoku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005297","name":"Medical University of Bialystok","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117383","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:47:31Z","timestamp":1759459651000},"page":"117383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Ex vivo study of the vasorelaxant activity induced by cannabigerol in human pulmonary artery- the role of endothelium, sex and selected clinical factors"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-3757","authenticated-orcid":false,"given":"Anna","family":"Krzy\u017cewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kloza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miros\u0142aw","family":"Koz\u0142owski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Galicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Koz\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2025.117383_b0005","first-page":"921","article-title":"Goods and bads of the endocannabinoid system as a therapeutic target: lessons learned after 30 years [published correction appears in Pharmacol Rev. 2023 Dec 15;76(4):622]","volume":"75","author":"Maccarrone","year":"2023","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.bcp.2025.117383_b0010","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/bph.12560","article-title":"Vascular targets for cannabinoids: animal and human studies","volume":"171","author":"Stanley","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.bcp.2025.117383_b0015","doi-asserted-by":"crossref","first-page":"10048","DOI":"10.3390\/ijms221810048","article-title":"Cannabinoids\u2014a new perspective in adjuvant therapy for pulmonary hypertension","volume":"22","author":"Krzy\u017cewska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117383_b0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2006.12.016","article-title":"Vo AC. 2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1\/2 signaling","volume":"559","author":"Su","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117383_b0025","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1097\/HJH.0b013e3282ef7a0a","article-title":"Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery","volume":"25","author":"Koz\u0142owska","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bcp.2025.117383_b0030","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/bjp.2008.371","article-title":"Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product","volume":"155","author":"Koz\u0142owska","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117383_b0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.phrs.2012.05.004","article-title":"Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery","volume":"66","author":"Baranowska-Kuczko","year":"2012","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.bcp.2025.117383_b0040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00210-014-0961-9","article-title":"Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries","volume":"387","author":"Baranowska-Kuczko","year":"2014","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117383_b0045","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/HJH.0000000000002333","article-title":"Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities","volume":"38","author":"Baranowska-Kuczko","year":"2020","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bcp.2025.117383_b0050","doi-asserted-by":"crossref","first-page":"R883","DOI":"10.1152\/ajpregu.00324.2016","article-title":"Activation of CB1 receptors by 2-arachidonoylglycerol attenuates vasoconstriction induced by U46619 and angiotensin II in human and rat pulmonary arteries","volume":"312","author":"Karpi\u0144ska","year":"2017","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bcp.2025.117383_b0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lfs.2017.11.020","article-title":"Mechanisms of l-alpha-lysophosphatidylinositol-induced relaxation in human pulmonary arteries","volume":"192","author":"Karpi\u0144ska","year":"2018","journal-title":"Life Sci."},{"issue":"19","key":"10.1016\/j.bcp.2025.117383_b0060","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.3390\/ijms21197077","article-title":"Cannabidiol ameliorates monocrotaline-induced pulmonary hypertension in rats","volume":"21","author":"Sadowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2025.117383_b0065","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.7150\/thno.55571","article-title":"Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function","volume":"11","author":"Lu","year":"2021","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.bcp.2025.117383_b0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/jpet.120.000340","article-title":"The pharmacological case for cannabigerol","volume":"376","author":"Nachnani","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2025.117383_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1561385","article-title":"Comprehensive mini-review: therapeutic potential of cannabigerol - focus on the cardiovascular system","volume":"16","author":"Krzy\u017cewska","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"14","key":"10.1016\/j.bcp.2025.117383_b0080","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.3390\/ijms23147929","article-title":"The origin and biomedical relevance of cannabigerol","volume":"23","author":"Jastrz\u0105b","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117383_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.871962","article-title":"Acute cannabigerol administration lowers blood pressure in mice","volume":"13","author":"Vernail","year":"2022","journal-title":"Front. Physiol."},{"issue":"20","key":"10.1016\/j.bcp.2025.117383_b0090","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.3390\/nu15204350","article-title":"How does CBG administration affect sphingolipid deposition in the liver of insulin-resistant rats?","volume":"15","author":"Bzd\u0119ga","year":"2023","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.bcp.2025.117383_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122992","article-title":"High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival","volume":"10","author":"Rabjerg","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2025.117383_b0100","first-page":"1289","article-title":"Laminar shear stress alters endothelial KCa2.3 expression in H9c2 cells partially via regulating the PI3K\/Akt\/p300 axis","volume":"43","author":"Li","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2025.117383_b0105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s12013-014-0497-0","article-title":"Effects of intermediate-conductance Ca(2+)-activated K(+) channels on human endometrial carcinoma cells","volume":"72","author":"Zhang","year":"2015","journal-title":"Cell Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.bcp.2025.117383_b0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12957-016-1056-5","article-title":"Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer","volume":"14","author":"Li","year":"2016","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bcp.2025.117383_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114234","article-title":"Cannabidiol inhibits lung proliferation in monocrotaline-induced pulmonary hypertension in rats","volume":"159","author":"Krzy\u017cewska","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2025.117383_b0120","series-title":"A Pharmacology Primer: Techniques for more Effective and Strategic Drug Discovery","author":"Kenakin","year":"2019"},{"issue":"3","key":"10.1016\/j.bcp.2025.117383_b0125","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/ijms23031427","article-title":"GPR18-mediated relaxation of human isolated pulmonary arteries","volume":"23","author":"Koz\u0142owska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2025.117383_b0130","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/biom12070889","article-title":"Characterization of endothelium-dependent relaxation in the saphenous artery and its caudal branches in young and old adult sprague dawley rats","volume":"12","author":"Wang","year":"2022","journal-title":"Biomolecules."},{"issue":"Pt A","key":"10.1016\/j.bcp.2025.117383_b0135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.prostaglandins.2015.09.002","article-title":"Ex vivo relaxations of pulmonary arteries induced by prostacyclin mimetics are highly dependent of the precontractile agents","volume":"121","author":"Benyahia","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"4","key":"10.1016\/j.bcp.2025.117383_b0140","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1476-5381.2008.00084.x","article-title":"Mechanisms of U46619-induced contraction of rat pulmonary arteries in the presence and absence of the endothelium","volume":"157","author":"McKenzie","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117383_b0145","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/jpet.114.217125","article-title":"Cannabidiol improves vasorelaxation in Zucker diabetic fatty rats through cyclooxygenase activation","volume":"351","author":"Wheal","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2025.117383_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1545044","article-title":"Promotion of nitric oxide production: mechanisms, strategies, and possibilities","volume":"16","author":"Gonzalez","year":"2025","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117383_b0155","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/cvr\/cvv179","article-title":"Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation","volume":"107","author":"Stanley","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2025.117383_b0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fphar.2017.00248","article-title":"In Vivo Cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker diabetic fatty rats","volume":"8","author":"Wheal","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117383_b0165","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1476-5381.2009.00132.x","article-title":"Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses\u2013relevance to cardiovascular pathologies and drug discovery","volume":"157","author":"Grgic","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117383_b0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1476-5381.2012.01986.x","article-title":"Activation of endothelial and epithelial K(Ca) 2.3 calcium-activated potassium channels by NS309 relaxes human small pulmonary arteries and bronchioles","volume":"167","author":"Kroigaard","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117383_b0175","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/ATVBAHA.122.318820","article-title":"Endothelial KCa3.1 and KCa2.3 mediate S1P (Sphingosine-1-Phosphate)-dependent vasodilation and blood pressure homeostasis","volume":"43","author":"Li","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117383_b0180","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117383_b0185","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s11481-012-9399-3","article-title":"A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis","volume":"7","author":"Granja","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bcp.2025.117383_b0190","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fphar.2018.00632","article-title":"Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes","volume":"9","author":"Navarro","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"Pt A","key":"10.1016\/j.bcp.2025.117383_b0195","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.phrs.2016.08.028","article-title":"The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries","volume":"113","author":"Stanley","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.bcp.2025.117383_b0200","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1167\/iovs.14-14879","article-title":"Role of endothelium in abnormal cannabidiol-induced vasoactivity in retinal arterioles","volume":"56","author":"Su","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2025.117383_b0205","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.pharep.2017.06.011","article-title":"ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BKCa channels, and nitric oxide dependent mechanisms","volume":"69","author":"L\u00f3pez-Dyck","year":"2017","journal-title":"Pharmacol. Rep."},{"issue":"9","key":"10.1016\/j.bcp.2025.117383_b0210","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.3390\/ijms22094833","article-title":"Beneficial changes in rat vascular endocannabinoid system in primary hypertension and under treatment with chronic inhibition of fatty acid amide hydrolase by URB597","volume":"22","author":"Baranowska-Kuczko","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117383_b0215","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.lfs.2016.03.014","article-title":"Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats","volume":"151","author":"Baranowska-Kuczko","year":"2016","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.bcp.2025.117383_b0220","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31373","article-title":"Dissecting the role of cannabinoids in vascular health and disease","volume":"239","author":"Guo","year":"2024","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117383_b0225","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm980363y","article-title":"Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists","volume":"42","author":"Lan","year":"1999","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2025.117383_b0230","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.bjp.0702351","article-title":"Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630","volume":"126","author":"Ross","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117383_b0235","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MNH.0000000000000103","article-title":"Molecular mechanisms regulating vascular tone by peroxisome proliferator activated receptor gamma","volume":"24","author":"Ketsawatsomkron","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"12","key":"10.1016\/j.bcp.2025.117383_b0240","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1089\/ars.2018.7695","article-title":"Redox biology of peroxisome proliferator-activated receptor-\u03b3 in pulmonary hypertension","volume":"31","author":"Tseng","year":"2019","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.bcp.2025.117383_b0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/HYPERTENSIONAHA.110.150375","article-title":"Rosiglitazone attenuates endothelin-1-induced vasoconstriction by upregulating endothelial expression of endothelin B receptor","volume":"56","author":"Tian","year":"2010","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.bcp.2025.117383_b0250","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.ATV.0000177805.65864.d4","article-title":"Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms","volume":"25","author":"Polikandriotis","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117383_b0255","doi-asserted-by":"crossref","first-page":"C899","DOI":"10.1152\/ajpcell.00474.2004","article-title":"Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production","volume":"288","author":"Hwang","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"24","key":"10.1016\/j.bcp.2025.117383_b0260","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1016\/j.lfs.2005.02.032","article-title":"Impaired expression of PPAR gamma protein contributes to the exaggerated growth of vascular smooth muscle cells in spontaneously hypertensive rats","volume":"77","author":"Xiong","year":"2005","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.bcp.2025.117383_b0265","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/01.RES.0000073585.50092.14","article-title":"Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth","volume":"92","author":"Ameshima","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.117383_b0270","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2014.12.019","article-title":"Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation","volume":"80","author":"Bijli","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117383_b0275","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1186\/s12885-016-2943-4","article-title":"Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility","volume":"16","author":"Rapp","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2025.117383_b0280","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.769589","article-title":"An overview of vascular dysfunction and determinants: the case of children of african ancestry","volume":"9","author":"Matjuda","year":"2021","journal-title":"Front. Pediatr."},{"issue":"4","key":"10.1016\/j.bcp.2025.117383_b0285","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1113\/JP275856","article-title":"Pulmonary vascular dysfunction in metabolic syndrome","volume":"597","author":"Willson","year":"2019","journal-title":"J. Physiol."},{"issue":"24","key":"10.1016\/j.bcp.2025.117383_b0290","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023603","article-title":"Pulmonary hypertension is associated with systemic arterial hypertension among patients with normal left ventricular diastolic function","volume":"10","author":"Itelman","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bcp.2025.117383_b0295","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1476-9255-7-54","article-title":"Hypercholesterolemia and microvascular dysfunction: interventional strategies","volume":"7","author":"Stapleton","year":"2010","journal-title":"J. Inflamm. (Lond)."},{"issue":"19","key":"10.1016\/j.bcp.2025.117383_b0300","doi-asserted-by":"crossref","first-page":"12331","DOI":"10.3390\/ijerph191912331","article-title":"Increased risk of chronic obstructive pulmonary disease in patients with hyperlipidemia: a nationwide population-based cohort study","volume":"19","author":"Yang","year":"2022","journal-title":"Int. J. Environ. Res. Public Health."},{"issue":"7","key":"10.1016\/j.bcp.2025.117383_b0305","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/10739680802308334","article-title":"Increased arachidonic acid-induced thromboxane generation impairs skeletal muscle arteriolar dilation with genetic dyslipidemia","volume":"15","author":"Goodwill","year":"2008","journal-title":"Microcirculation"},{"issue":"6","key":"10.1016\/j.bcp.2025.117383_b0310","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/01.HYP.0000146907.82869.f2","article-title":"Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles","volume":"44","author":"Zhang","year":"2004","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcp.2025.117383_b0315","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1476-5381.2011.01308.x","article-title":"AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats","volume":"163","author":"Yang","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117383_b0320","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2353\/ajpath.2007.060860","article-title":"Relative reduction of endothelial nitric-oxide synthase expression and transcription in atherosclerosis-prone regions of the mouse aorta and in an in vitro model of disturbed flow","volume":"171","author":"Won","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2025.117383_b0325","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.vph.2017.10.001","article-title":"The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on KCa2.3\/KCa3.1-EDH-type relaxation in rat small mesenteric arteries","volume":"99","author":"Kloza","year":"2017","journal-title":"Vascul. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117383_b0330","doi-asserted-by":"crossref","first-page":"H2275","DOI":"10.1152\/ajpheart.00949.2006","article-title":"Reduced expression of SKCa and IKCa channel proteins in rat small mesenteric arteries during angiotensin II-induced hypertension","volume":"292","author":"Hilgers","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117383_b0335","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/CIRCRESAHA.121.318082","article-title":"Pathophysiology of hypertension: the mosaic theory and beyond","volume":"128","author":"Harrison","year":"2021","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117383_b0340","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01095-2024","article-title":"Pathology and pathobiology of pulmonary hypertension: current insights and future directions","volume":"64","author":"Guignabert","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.bcp.2025.117383_b0345","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/ph15091119","article-title":"Why multitarget vasodilatory (endo)cannabinoids are not effective as antihypertensive compounds after chronic administration: comparison of their effects on systemic and pulmonary hypertension","volume":"15","author":"Remiszewski","year":"2022","journal-title":"Pharmaceuticals (Basel)."},{"issue":"1","key":"10.1016\/j.bcp.2025.117383_b0350","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1476-5381.2009.00515.x","article-title":"Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist","volume":"159","author":"Cascio","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2025.117383_b0355","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1113\/jphysiol.2005.094292","article-title":"Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed","volume":"568","author":"Poblete","year":"2005","journal-title":"J. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2025.117383_b0360","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mvr.2005.02.001","article-title":"Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium","volume":"69","author":"Chen","year":"2005","journal-title":"Microvasc. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117383_b0365","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.ATV.21.1.28","article-title":"Potassium channel function in vascular disease","volume":"21","author":"Sobey","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"19","key":"10.1016\/j.bcp.2025.117383_b0370","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery","volume":"57","author":"Anighoro","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117383_b0375","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fphar.2015.00205","article-title":"Multi-target pharmacology: possibilities and limitations of the \u201cskeleton key approach\u201d from a medicinal chemist perspective","volume":"6","author":"Talevi","year":"2015","journal-title":"Front Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117383_b0380","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jat.4409","article-title":"Physiologically based pharmacokinetic modeling and simulation of cannabinoids in human plasma and tissues","volume":"43","author":"Liu","year":"2023","journal-title":"J. Appl. Toxicol."},{"issue":"21","key":"10.1016\/j.bcp.2025.117383_b0385","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1021\/acs.biochem.2c00383","article-title":"Metabolites of cannabigerol generated by human cytochrome P450s are bioactive","volume":"61","author":"Roy","year":"2022","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.bcp.2025.117383_b0390","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1089\/can.2023.0174","article-title":"Impact of dietary fat and oral delivery system on cannabigerol pharmacokinetics in adults","volume":"9","author":"Story","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"issue":"12","key":"10.1016\/j.bcp.2025.117383_b0395","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1373\/clinchem.2016.263475","article-title":"Free and glucuronide whole blood cannabinoids' pharmacokinetics after controlled smoked, vaporized, and oral cannabis administration in frequent and occasional cannabis users: identification of recent cannabis intake","volume":"62","author":"Newmeyer","year":"2016","journal-title":"Clin. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T08:34:44Z","timestamp":1761381284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":79,"alternative-id":["S0006295225006483"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117383","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex vivo study of the vasorelaxant activity induced by cannabigerol in human pulmonary artery- the role of endothelium, sex and selected clinical factors","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117383"}}